Hainan Provincial Health Commission

Forwarding the Notification of Including Simnotrelvir Tablets/Ritonavir Tablets (Co-Packaged) and Deuremidevir Hydrobromide Tablets in Diagnosis and Treatment Plan for Novel Coronavirus Infection

To the health commissions of all cities, counties, and autonomous counties; affiliated hospitals of Hainan Medical University; and all medical institutions directly under the commission:

The Notification on Including Simnotrelvir Tablets/Ritonavir Tablets (Co-Packaged) and Deuremidevir Hydrobromide Tablets in Diagnosis and Treatment Plan for Novel Coronavirus Infection (No. 51[2023] of the General Office of the National Health Commission for Emergency) issued by the General Office of the National Health Commission and the Comprehensive Department of the National Administration of Traditional Chinese Medicine is hereby forwarded to you. Please follow and execute it.

Hainan Provincial Health Commission

March 4, 2023

(This document is actively disclosed to the public)

Proofreader: Xia Lijin